Abstract:Background and aim A plateau in oxygen uptake ( V ̇ O 2 ) during an incremental cardiopulmonary exercise test (CPET) to volitional exhaustion appears less likely to occur in special and clinical populations. Secondary maximal oxygen uptake ( V ̇ O 2 max ) criteria have been shown to commonly underestimate the actual V ̇ O 2 max . The verification phase protocol might determine the occurrence of ‘true’ V ̇ O 2 max in these populations. The primary aim of the current study was to systematically review and provide a meta-analysis on the suitability of the verification phase for confirming ‘true’ V ̇ O 2 max in special and clinical groups. Secondary aims were to explore the applicability of the verification phase according to specific participant characteristics and investigate which test protocols and procedures minimise the differences between the highest V ̇ O 2 values attained in the CPET and verification phase. Methods Electronic databases (PubMed, Web of Science, SPORTDiscus, Scopus, and EMBASE) were searched using specific search strategies and relevant data were extracted from primary studies. Studies meeting inclusion criteria were systematically reviewed. Meta-analysis techniques were applied to quantify weighted mean differences (standard deviations) in peak V ̇ O 2 from a CPET and a verification phase within study groups using random-effects models. Subgroup analyses investigated the differences in V ̇ O 2 max according to individual characteristics and test protocols. The methodological quality of the included primary studies was assessed using a modified Downs and Black checklist to obtain a level of evidence. Participant-level V ̇ O 2 data were analysed according to the threshold criteria reported by the studies or the inherent measurement error of the metabolic analysers and displayed as Bland-Altman plots. Results Forty-three studies were included in the systematic review, whilst 30 presented quantitative information for meta-analysis. Within the 30 studies, the highest mean V ̇ O 2 values attained in the CPET and verification phase protocols were similar (mean difference = -0.00 [95% confidence intervals, CI = -0.03 to 0.03] L·min -1 , p = 0.87; level of evidence, LoE: strong). The specific clinical groups with sufficient primary studies to be meta-analysed showed a similar V ̇ O 2 max between the CPET and verification phase ( p > 0.05, LoE: limited to strong). Across all 30 studies, V ̇ O 2 max was not affected by differences in test protocols ( p > 0.05; LoE: moderate to strong). Only 23 (53.5%) of the 43 reviewed studies reported how many participants achieved a lower, equal, or higher V ̇ O 2 value in the verification phase versus the CPET or reported or supplied participant-level V ̇ O 2 data for this information to be obtained. The percentage of participants that achieved a lower, equal, or higher V ̇ O 2 value in the verification phase was highly variable across studies (e.g. the percentage that achieved a higher V ̇ O 2 in the verification phase ranged from 0% to 88.9%). Conclusion Group-level verification phase data appear useful for confirming a specific CPET protocol likely elicited V ̇ O 2 max , or a reproducible V ̇ O 2 p e a k , for a given special or clinical group. Participant-level data might be useful for confirming whether specific participants have likely elicited V ̇ O 2 max , or a reproducible V ̇ O 2 p e a k , however, more research reporting participant-level data is required before evidence-based guidelines can be given. Trial registration PROSPERO ( CRD42021247658 ) https://www.crd.york.ac.uk/prospero .

Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease

The Role of Cardiopulmonary Exercise Testing in Assessment of Patients with Interstitial Lung Disease

Cardiopulmonary exercise testing: current applications

A Summed Score From Cardiopulmonary Exercise Test Parameters Predicts 1-Year Mortality in Newly Diagnosed Interstitial Lung Disease

The clinical value of cardiopulmonary exercise testing in the modern era

Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19

P310 CARDIOPULMONARY EXERCISE TEST IN THE EVALUATION OF A PATIENT WITH HFREF: THE IMPORTANCE IN THE ANALYSIS OF GAS KINETICS

ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases

Utility of cardiopulmonary exercise testing in children and adolescents with non-cystic fibrosis bronchiectasis and primary ciliary dyskinesia.

Cardiopulmonary Exercise Test Parameters in Athletic Population: A Review

Cardiopulmonary exercise test to detect cardiac dysfunction from pulmonary vascular disease

Comparison of muscle oxygenation, dyspnea, oxygen uptake and energy expenditure during upper and lower limb cardiopulmonary exercise test in patients with ILD

Confirming the attainment of maximal oxygen uptake within special and clinical groups: A systematic review and meta-analysis of cardiopulmonary exercise test and verification phase protocols

Identifying limitations to exercise with incremental cardiopulmonary exercise testing: a scoping review

Exercise Physiology Impairments of Patients With Amyotrophic Lateral Sclerosis: Cardiopulmonary Exercise Testing Findings

Pulmonary Vascular Disease and Cardiopulmonary Exercise Testing

Cardiorespiratory response of the incremental step test in people with chronic obstructive pulmonary disease

Practical guide to cardiopulmonary exercise testing in adults

Reliability of maximum oxygen uptake in cardiopulmonary exercise testing with continuous laryngoscopy

Performance comparison of e-Lung with densitometry in the CT evaluation of patients with IPF

P722 The steep ramp test is a valid practical test to assess cardiorespiratory fitness in patients with inflammatory bowel disease